Starmab Biologies Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 5

Starmab Biologies General Information

Description

Developer of anti-infective macromolecule medicines designed for fungi, bacteria and viruses. The company focuses on antibody drug discovery, pharmaceutical research system and development capabilities, enabling to solve clinical problems that cannot be solved by existing anti-infective drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 208, Building 2, No. 40, Suhong West Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215028
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 208, Building 2, No. 40, Suhong West Road
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215028
  • China
+86 0512

Starmab Biologies Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starmab Biologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 05-Mar-2025 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 14-Feb-2023 Completed Pre-Clinical Trials
To view Starmab Biologies’s complete valuation and funding history, request access »

Starmab Biologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wuxi Capital Group Venture Capital Minority
Zhejiang Huahai Pharmaceutical Corporation Minority
Fosun Health Capital Corporate Venture Capital Minority
Suzhou Tahoe Venture Capital Venture Capital Minority
Yaoyou Pharmaceutical Corporation Minority
To view Starmab Biologies’s complete investors history, request access »

Starmab Biologies FAQs

  • When was Starmab Biologies founded?

    Starmab Biologies was founded in 2020.

  • Where is Starmab Biologies headquartered?

    Starmab Biologies is headquartered in Suzhou, China.

  • What industry is Starmab Biologies in?

    Starmab Biologies’s primary industry is Drug Discovery.

  • Is Starmab Biologies a private or public company?

    Starmab Biologies is a Private company.

  • What is Starmab Biologies’s current revenue?

    The current revenue for Starmab Biologies is .

  • How much funding has Starmab Biologies raised over time?

    Starmab Biologies has raised $14.7M.

  • Who are Starmab Biologies’s investors?

    Wuxi Capital Group, Zhejiang Huahai Pharmaceutical, Fosun Health Capital, Suzhou Tahoe Venture Capital, and Yaoyou Pharmaceutical have invested in Starmab Biologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process